Ionis Pharmaceuticals Stock Forward View - Triple Exponential Smoothing

IONS Stock  USD 82.67  1.21  1.44%   
Ionis Stock outlook is based on your current time horizon.
At this time, The RSI of Ionis Pharmaceuticals' share price is at 56. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Ionis Pharmaceuticals, making its price go up or down.

Momentum 56

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of Ionis Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ionis Pharmaceuticals and does not consider all of the tangible or intangible factors available from Ionis Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Ionis Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Ionis Pharmaceuticals hype-based prediction, you can estimate the value of Ionis Pharmaceuticals from the perspective of Ionis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of Ionis Pharmaceuticals on the next trading day is expected to be 82.90 with a mean absolute deviation of 1.39 and the sum of the absolute errors of 82.18.

Ionis Pharmaceuticals after-hype prediction price

    
  USD 82.87  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Ionis Pharmaceuticals to cross-verify your projections.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

Ionis Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Ionis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ionis using various technical indicators. When you analyze Ionis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Triple exponential smoothing for Ionis Pharmaceuticals - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Ionis Pharmaceuticals prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Ionis Pharmaceuticals price movement. However, neither of these exponential smoothing models address any seasonality of Ionis Pharmaceuticals.

Ionis Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 2nd of February

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Ionis Pharmaceuticals on the next trading day is expected to be 82.90 with a mean absolute deviation of 1.39, mean absolute percentage error of 2.81, and the sum of the absolute errors of 82.18.
Please note that although there have been many attempts to predict Ionis Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ionis Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ionis Pharmaceuticals Stock Forecast Pattern

Backtest Ionis Pharmaceuticals  Ionis Pharmaceuticals Price Prediction  Buy or Sell Advice  

Ionis Pharmaceuticals Forecasted Value

In the context of forecasting Ionis Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ionis Pharmaceuticals' downside and upside margins for the forecasting period are 80.91 and 84.88, respectively. We have considered Ionis Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
82.67
82.90
Expected Value
84.88
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Ionis Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Ionis Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.2509
MADMean absolute deviation1.393
MAPEMean absolute percentage error0.0179
SAESum of the absolute errors82.1843
As with simple exponential smoothing, in triple exponential smoothing models past Ionis Pharmaceuticals observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Ionis Pharmaceuticals observations.

Predictive Modules for Ionis Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ionis Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
80.8882.8784.86
Details
Intrinsic
Valuation
LowRealHigh
74.4090.7992.78
Details
Bollinger
Band Projection (param)
LowMiddleHigh
76.5580.4084.25
Details

Ionis Pharmaceuticals After-Hype Price Density Analysis

As far as predicting the price of Ionis Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ionis Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ionis Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Ionis Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Ionis Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ionis Pharmaceuticals' historical news coverage. Ionis Pharmaceuticals' after-hype downside and upside margins for the prediction period are 80.88 and 84.86, respectively. We have considered Ionis Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
82.67
82.87
After-hype Price
84.86
Upside
Ionis Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Ionis Pharmaceuticals is based on 3 months time horizon.

Ionis Pharmaceuticals Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Ionis Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ionis Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ionis Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.21 
1.99
 0.00  
  0.28 
0 Events / Month
2 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
82.67
82.87
0.24 
0.00  
Notes

Ionis Pharmaceuticals Hype Timeline

Ionis Pharmaceuticals is currently traded for 82.67. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.28. Ionis is estimated to increase in value after the next headline, with the price projected to jump to 82.87 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is projected to be 0.24%, whereas the daily expected return is currently at 0.21%. The volatility of related hype on Ionis Pharmaceuticals is about 149.06%, with the expected price after the next announcement by competition of 82.95. The company reported the previous year's revenue of 705.14 M. Net Loss for the year was (453.9 M) with profit before overhead, payroll, taxes, and interest of 73.71 M. Given the investment horizon of 90 days the next estimated press release will be uncertain.
Check out Historical Fundamental Analysis of Ionis Pharmaceuticals to cross-verify your projections.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

Ionis Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Ionis Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Ionis Pharmaceuticals' future price movements. Getting to know how Ionis Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ionis Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ASNDAscendis Pharma AS 0.00 0 per month 2.46  0.07  4.74 (4.38) 12.80 
BBIOBridgeBio Pharma 1.25 7 per month 1.75  0.13  4.23 (2.55) 12.16 
RVMDRevolution Medicines 12.18 8 per month 2.99  0.18  4.56 (2.52) 45.50 
ROIVRoivant Sciences 0.00 0 per month 1.57  0.07  3.56 (2.84) 9.44 
SMMTSummit Therapeutics PLC 0.00 0 per month 0.00 (0.09) 5.41 (5.97) 23.61 
BMRNBiomarin Pharmaceutical 0.00 0 per month 1.53  0.04  3.15 (2.32) 22.06 
EXELExelixis(0.08)10 per month 1.75  0.01  4.06 (2.93) 11.45 
MDGLMadrigal Pharmaceuticals 0.00 0 per month 2.03  0.09  7.29 (3.26) 16.78 
MRNAModerna 0.00 0 per month 3.55  0.20  9.21 (6.55) 23.11 
GHGuardant Health 0.00 0 per month 1.93  0.09  4.16 (3.15) 14.51 

Other Forecasting Options for Ionis Pharmaceuticals

For every potential investor in Ionis, whether a beginner or expert, Ionis Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ionis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ionis. Basic forecasting techniques help filter out the noise by identifying Ionis Pharmaceuticals' price trends.

Ionis Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ionis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Ionis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ionis Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ionis Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Ionis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ionis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ionis Pharmaceuticals stock market strength indicators, traders can identify Ionis Pharmaceuticals entry and exit signals to maximize returns.

Ionis Pharmaceuticals Risk Indicators

The analysis of Ionis Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ionis Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ionis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Ionis Pharmaceuticals

The number of cover stories for Ionis Pharmaceuticals depends on current market conditions and Ionis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ionis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ionis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Ionis Pharmaceuticals Short Properties

Ionis Pharmaceuticals' future price predictability will typically decrease when Ionis Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ionis Pharmaceuticals often depends not only on the future outlook of the potential Ionis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ionis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding149.5 M
Cash And Short Term Investments2.3 B

Additional Tools for Ionis Stock Analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.